Skip to main content


The National Institutes of Health (NIH) campuses host a variety of events that inform, challenge, and unite the biomedical research community. IRP investigators lead or participate in many of these events, and they regularly present their work at scientific conferences at the NIH and around the world. We invite you to learn about (and possibly join us in) some of our upcoming events:

Wednesday, September 3, 2014, 3:00 pm to 4:00 pm

Masur Auditorium, NIH Clinical Center (Bldg 10)

Andrew Feinberg, M.D., M.P.H., Daniel Coit Gilman Scholar, King Fahd Professor of Medicine, Oncology, Molecular Biology/Genetics, and Biostatistics; and director of the Center for Epigenetics at Johns Hopkins University, will present the first talk of the 2014-2015 Wednesday Afternoon Lecture Series (WALS). Dr. Feinberg's lecture title will be announced as the date approaches.

from the speaker:  “Our laboratory is studying the epigenetic basis of normal development and disease, including cancer, aging, and neuropsychiatric illness.  Epigenetics involves changes in DNA and chromatin structure that are remembered by the cell when it divides, such as DNA methylation, genomic imprinting, and histone modification. Epigenetics is important because many of the differences between a germ cell and a somatic cell, or two different tissue types, or a cancer and a normal cell, involve epigenetic changes rather than mutation in the DNA sequence. Early work from our group involved the discovery of altered DNA methylation in cancer, as well as common epigenetic (methylation and imprinting) variants in the population that may be responsible for a significant population-attributable risk of cancer. Over the last few years, our laboratory has pioneered the field of epigenomics, i.e. epigenetics at a genome-scale level, founding the first NIH-supported NIH epigenome center in the country, and developing many novel tools for molecular and statistical analysis. Several discoveries and avenues of research have arisen from our epigenome center.”

Come join your colleagues, DDIR Michael Gottesman and NIH Director Francis Collins at these top-notch lectures, even if you think they are outside of your area of interest. The WALS website will be updated with a new schedule for this season soon.

Thursday, October 9, 2014 to Friday, October 10, 2014

Masur and Lipsett Auditoriums, NIH Clinical Center (Bldg 10)

This two-day national symposium addresses recent advances in the field and should be an exciting forum for discussion and debate on the current understanding of the immunotherapy of cancer.

Sessions will include:

  • Adoptive Cell Therapies
  • Genetic Engineering of the Immune System
  • Checkpoint Modulators
  • Other Approaches to Cancer Immunotherapy

Registration is now open and abstracts are being accepted for the poster session. Deadline for abstract submission is August 15, 2014. Registration is free, but seating is limited, so be sure to register early.

For conference related questions, please contact Heather Leonard.